InMode Ltd. Stock News

Investors seeking higher returns on their capital often turn to hypergrowth stocks. These assets have great potential and can comfortably exceed the returns of the S&P 500 if the companies continue to

InMode Ltd.'s stock INMD, +2.31% rose 2.5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance.

InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of 18

Doximity's massive platform for doctors is the perfect setting for healthcare advertisers. Declining fertility trends make Progyny's services all the more important to its customers.

Investing in high-quality businesses trading at historical discounts is a prudent strategy with the potential for market-beating returns. In this article, we will explore three such exceptional stocks

Buying and holding stocks for the long term takes up less time and can produce solid returns. Instead of looking at technical indicators and studying the market every day, investors can focus on the f

Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective dr

The "Halftime Report" traders give their top picks to watch for the second half.

Here is how InMode (INMD) and Adma Biologics (ADMA) have performed compared to their sector so far this year.

InMode is a leader in the niche industry of minimally invasive medical treatment solutions, with strong brand recognition and a growing market presence. The company has an experienced leadership team,

With the market facing myriad pressure points – predominantly stubbornly high inflation along with general anxieties about an incoming recession – the bright side is that investors have options re

While it's a general rule of thumb that you get what you pay for, in the market, you can sneak in some overlooked compelling discounts, which might be the case with the below best affordable stocks to

CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.

Now that it has sold its logistics business, Shopify once again has a strong profit margin. InMode makes increasingly popular medical devices that perform noninvasive and minimally invasive cosmetic p

Anthony Petrone, senior medical devices analyst at Mizuho, joins 'The Exchange' to discuss medical technology gaining share, the bull case for Medtronic, and how medication advancements could impact t